Brief: Novavax Announces Memorandum Of Understanding To Explore Expansion Of Covid-19 Vaccine Activities In South Korea
May 22 (Reuters) - Novavax Inc NVAX.O :
* NOVAVAX ANNOUNCES MEMORANDUM OF UNDERSTANDING TO EXPLORE
EXPANSION OF COVID-19 VACCINE ACTIVITIES IN SOUTH KOREA
* NOVAVAX - NOVAVAX AND SK BIOSCIENCE REAFFIRM PARTNERSHIP
DURING
MEETING WITH SOUTH KOREAN LEADERS
* NOVAVAX-MOU BUILDS ON EXISTING MANUFACTURING, LICENSING
COLLABORATION, INTENDED TO PROVIDE BROAD ACCESS TO NVX-COV2373
IN REPUBLIC OF KOREA & GLOBALLY
* NOVAVAX-CO,SK AGREED TO EXPLORE DEVELOPMENT OF NEW VACCINE
PRODUCTS,INCLUDING COVID-19 VARIANT VACCINES AND/OR
INFLUENZA-COVID-19 COMBINATION VACCINE
Source text for Eikon: ID:nPn4gH9dPa
Further company coverage: NVAX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on SK Bioscience Co
See all newsBrief: SK Bioscience Joins Forces With Global Institutions To Advance Rotavirus Vaccine Development
Brief: SK Bioscience Files For First-In-Human Trial Of Universal Coronavirus Vaccine GBP511 Phase 1/2 Study In Australia
Novavax beats quarterly revenue estimates on milestone payment (updated)
Brief: Sk Bioscience Submits Ind For Phase 1/2 Clinical Trial Of Adjuvanted Influenza Vaccine Candidate
Brief: SK Bioscience - Wins Patent Lawsuit Against Pfizer Over Pneumococcal Vaccine